Disease monitoring of biologic treatment in IBD: early impact and future implications of COVID-19 pandemic | Frontline Gastroenterology

Subscribe
Log In More

Log in via Institution
Log in via OpenAthens
Log in via BSG

Log in using your username and password
For personal accounts OR managers of institutional accounts

Username *

Password *

Forgot your log in details?Register a new account?
Forgot your user name or password?
Basket
Search More

Search for this keyword

Advanced search

Close More
Main menu

CME/CPD

Latest content

Current issue

Archive

Authors

About
Subscribe
Log in More

Log in via Institution
Log in via OpenAthens
Log in via BSG

Log in using your username and password
For personal accounts OR managers of institutional accounts

Username *

Password *

Forgot your log in details?Register a new account?
Forgot your user name or password?
BMJ Journals

Citation Tools

Colorectal

Opinion

Disease monitoring of biologic treatment in IBD: early impact and future implications of COVID-19 pandemic

Download to a citation manager

Download the citation for this article by clicking on one of the following citation managers:

Cite this article as:: Shields S, Dunlop A, Seenan JP, et al

Disease monitoring of biologic treatment in IBD: early impact and future implications of COVID-19 pandemic

Frontline Gastroenterology 2021;12:345-347.